Modification of radiation sensitivity in radiation therapy by combination of molecular target therapy

结合分子靶向治疗改变放射治疗的放射敏感性

基本信息

  • 批准号:
    16390334
  • 负责人:
  • 金额:
    $ 9.09万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 财政年份:
    2004
  • 资助国家:
    日本
  • 起止时间:
    2004 至 2006
  • 项目状态:
    已结题

项目摘要

Correlations between radiation response and various biological parameters including oncogenes, apoptosis relating gene expressions of tumors and hypoxia relating proteins were investigated for prediction of radiation sensitivity predominantly relating local control probability following radiation therapy.Immunohistochemical study and various DNA/RNA analysis for human specimens were performed for obtaining parameters relating to radiation sensitivity as well as analysis for tumor cell lines and experimental animals as materials. Prognosis was analyzed by various parameters including p21, p27, p53 protein expression, inducible NOS (iNOS), Hypoxia-inducible factor-1α (HIF-1α) and Cyclooxygenase-2 (Cox-2).Of 38 patients, high expression of HIF-1α, p53, bax, and bcl-2 were seen in 17 (45%), 22 (58%), 15 (39%), and 15 (39%) patients, respectively, and 28 patients (74%) showed the positive infection with HPV. There was a significant positive correlation between high HIF-1α expression and dis … More ease recurrence (p<0.05). Furthermore, HIF-1α had a significant correlation with the recurrence free survival rate (p=0.04). No statistical significance was noted between high HIF-1α expression and local control rate (p=0.17), whereas HIF-1α status predicted distant metastasis with strong significance (p=0.03). Conversely, other factors demonstrated no impact on clinical outcome of patients with stage IIIB cervical carcinoma. HIF-1α is an important prognostic factor, especially for predicting future metastasis after radiation therapy for patients with Stage IIIB squamous cell carcinoma of the cervix.Cyclooxygenase-2 (Cox-2) impairs treatment effects of radiotherapy for cervical cancer by inhibition of radiation-induced apoptosis.COX-2 plays a pivotal role in regulation of radiation-induced apoptosis. The relationship between COX-2 expression and postradiotherapy outcomes of patients with cervical cancer was analyzed for biopsy specimens from 47 consecutive patients who had undergone definitive radiotherapy alone or radiotherapy combined with chemotherapy. The COX-2 expression rate of the pretreatment samples was 46.1% +/- 21.0%, and the apoptotic index (AI) 1 week after start of radiotherapy was 2.1% +/- 0.9%. There was a significant negative correlation between the pretreatment COX-2 expression and the AI during radiotherapy (r=-0.52, p=0.0002). Complete response rates were 59% for COX-2 positive patients compared with 80% for COX-2 negative patients (p=0.12). The 2-year local control rate for COX-2 positive patients was 71.3%, whereas the corresponding rate for COX-2 negative patients was 96.0% (p=0.06). these results firstly prove clinically that COX-2 can make cervical squamous cell carcinomas more refractory to radiotherapy by inhibition of radiation-induced apoptosis. Furthermore, expression of COX-2 may be a good indicator to predict local tumor control after radiotherapy.Bystander responses of human lung cancer cell line induced by high LET heavy-ion irradiation.Lung cancer cells were irradiated with a collimated heavy-ion microbeam single cell irradiation system, which allows selected cells to be individually hit with defined number of heavy charged particles at JAERI-Takasaki. This system has been developed to study radiobiological processes in hit cells and bystander cells exposed to low dose and low dose-rate high-LET radiations, in ways that cannot be achieved using conventional broad-field exposures. The individual cultured cells grown in special dishes were irradiated in the atmosphere with a single or defined numbers of carbon beams. Bystander effect was induced by carbon irradiation and blocked by addition of gap inhibitor. Less
辐射反应与包括癌基因在内的各种生物学参数之间的相关性,肿瘤细胞凋亡相关基因和缺氧相关蛋白的表达被用来预测放射敏感性,主要与放射治疗后的局部控制概率有关。对人样本进行RNA分析以获得与辐射敏感性相关的参数以及对肿瘤细胞系的分析,实验动物为材料。结果:38例患者中,17例(45%)、22例(58%)、15例(39%)、22例(58%)、23例(58%)、24例(58%)、25例(58%)、22例(58%)、23例(58%)、22例(58%)HPV阳性28例(74%)。HIF-1α的高表达与肿瘤的分化程度呈显著正相关。 ...更多信息 减少复发(P<0.05)。此外,HIF-1α与无复发生存率显著相关(p=0.04)。HIF-1α高表达与局部控制率之间无统计学意义(p=0.17),而HIF-1α状态预测远处转移具有显著意义(p=0.03)。相反,其他因素对IIIB期宫颈癌患者的临床结局无影响。HIF-1α是预测IIIB期宫颈鳞癌放疗后转移的重要预后因子,而环氧化酶2(考克斯-2)通过抑制放疗诱导的细胞凋亡而影响放疗效果,考克斯-2在调节放疗诱导的细胞凋亡中起关键作用。分析了47例连续接受单纯放疗或放疗联合化疗的宫颈癌患者的活检标本中考克斯-2表达与放疗后结局的关系。放疗前标本的考克斯-2表达率为46.1% ± 21.0%,放疗开始后1周的凋亡指数(AI)为2.1% ± 0.9%。放疗前考克斯-2表达与放疗期间AI呈显著负相关(r=-0.52,p =0.0002)。考克斯-2阳性患者的完全缓解率为59%,而考克斯-2阴性患者的完全缓解率为80%(p=0.12)。考克斯-2阳性患者的2年局部控制率为71.3%,而考克斯-2阴性患者的相应率为96.0%(p=0.06)。这些结果首次在临床上证明了考克斯-2通过抑制放射诱导的细胞凋亡而使宫颈鳞状细胞癌对放射治疗更难治。考克斯-2的表达可能是预测放疗后局部肿瘤控制的良好指标。高LET重离子照射诱导的人肺癌细胞系的旁观者反应。该系统已被开发用于研究低剂量和低剂量率高LET辐射下的击中细胞和旁观者细胞的放射生物学过程,这是使用常规宽场照射无法实现的。在特殊培养皿中生长的单个培养细胞在大气中用单个或限定数量的碳束照射。旁观者效应由碳辐射诱导,并被gap抑制剂阻断。少

项目成果

期刊论文数量(39)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
CT-fluoroscopy guided interstitial brachytherapy with image-based trestment planning for unresectable locally recurrent rectal carcinoma
CT 透视引导间质近距离放射治疗和基于图像的治疗计划治疗不可切除的局部复发直肠癌
  • DOI:
  • 发表时间:
    2004
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Sakurai H;Mitsuhashi N;Harashima K;Muramatsu H;Hasegawa M;et al.
  • 通讯作者:
    et al.
Cyclooxygenase-2 impairs treatment effects of radiotherapy for cervical cancer by inhibition of radiation-induced apoptosis
Challenge of Hyperthermia Combined with Chemotherapy or Chemo-radiotherapy for Unresectable Intrathoracic Malignant Tumors : A Preliminary Result
热疗联合化疗或放化疗治疗不可切除的胸内恶性肿瘤的挑战:初步结果
  • DOI:
  • 发表时间:
    2005
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Ishikawa H;Nakayama Y;Sakurai H;Kitamoto Y;Nonaka T;Kiyohara H;Shioya M;Wakatsuki M;Kawamura H;Hasegawa M;Nakano T
  • 通讯作者:
    Nakano T
Rectal bleeding after high dose rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy (EBRT) for localized prostate cancer : Impact of the rectal dose in high dose rate (HDR) brachytherapy on the occurrence of grade 2 or
高剂量率(HDR)近距离放射治疗联合大分割外照射放射治疗(EBRT)治疗局限性前列腺癌后直肠出血:高剂量率(HDR)近距离放射治疗中直肠剂量对2级或2级的影响
Radiation therapy for T2NO laryngeal cancer : A retrospective analysis for the impact of concurrent chemotherapy on local control.
T2NO 喉癌的放射治疗:同步化疗对局部控制影响的回顾性分析。
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

NAKANO Takashi其他文献

慢性拘束ストレス後の中脳中心灰白質におけるGFAPおよびglutamate transporterの減少
慢性束缚应激后中脑灰质中央 GFAP 和谷氨酸转运蛋白减少
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
    OHMICHI Yusuke;OHMICHI Mika;SAKURAI Hiroki ;NAKANO Takashi;ASAMOTO Ken;USHIDA Takahiro;SATO Jun;井辺弘樹
  • 通讯作者:
    井辺弘樹

NAKANO Takashi的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('NAKANO Takashi', 18)}}的其他基金

Supply Platform of Short-lived Radioisotopes
短寿命放射性同位素供应平台
  • 批准号:
    16H06278
  • 财政年份:
    2019
  • 资助金额:
    $ 9.09万
  • 项目类别:
    Grant-in-Aid for Scientific Research on Innovative Areas ― Platforms for Advanced Technologies and Research Resources
Development of High Intensity Laser-Electron Photon beam with synchronized laser injection
同步激光注入高强度激光电子光子束的开发
  • 批准号:
    16K13806
  • 财政年份:
    2016
  • 资助金额:
    $ 9.09万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
Basic research on Sophistication of Medical Si/CdTe compton camera
医用Si/CdTe康普顿相机精密度基础研究
  • 批准号:
    24659557
  • 财政年份:
    2012
  • 资助金额:
    $ 9.09万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
Development and evaluation of a novel method for inactivation of clinical wastewater based on electrolysis
基于电解的临床废水灭活新方法的开发和评价
  • 批准号:
    22510091
  • 财政年份:
    2010
  • 资助金额:
    $ 9.09万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Management of environment to secure the quality of educators in the introduction of the new-curriculum
新课改环境管理确保教育工作者素质
  • 批准号:
    21592730
  • 财政年份:
    2009
  • 资助金额:
    $ 9.09万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Translational research for establishment of heavy ion radiotherapy for cancer
建立癌症重离子放射治疗的转化研究
  • 批准号:
    20390324
  • 财政年份:
    2008
  • 资助金额:
    $ 9.09万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Research on the driving, lubrication and self assembled mechanism of bacterial flagellar motor
细菌鞭毛马达驱动、润滑及自组装机制研究
  • 批准号:
    17560115
  • 财政年份:
    2005
  • 资助金额:
    $ 9.09万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Study of Exotic Baryon with High Intensity Photon Beam
高强度光子束研究奇异重子
  • 批准号:
    17070004
  • 财政年份:
    2005
  • 资助金额:
    $ 9.09万
  • 项目类别:
    Grant-in-Aid for Scientific Research on Priority Areas
Study of reaction mechanism of Theta+photo-production
Theta光产生反应机理研究
  • 批准号:
    16204017
  • 财政年份:
    2004
  • 资助金额:
    $ 9.09万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
Research on the lubrication mechanism of bacterial flagellar motor and applications to nano machines
细菌鞭毛马达润滑机理及其在纳米机器中的应用研究
  • 批准号:
    15560113
  • 财政年份:
    2003
  • 资助金额:
    $ 9.09万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)

相似海外基金

Hypoxia Inducible Factor-Proline Hydroxylase (HIF-PH) Inhibitors as a Treatment Strategy for Combined Radiation Injury
缺氧诱导因子脯氨酸羟化酶 (HIF-PH) 抑制剂作为复合放射损伤的治疗策略
  • 批准号:
    23K08477
  • 财政年份:
    2023
  • 资助金额:
    $ 9.09万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Investigating the effect of ionising radiation on cyclic hypoxia-induced replication catastrophe and genome instability in tumours
研究电离辐射对周期性缺氧诱导的肿瘤复制灾难和基因组不稳定性的影响
  • 批准号:
    2745245
  • 财政年份:
    2022
  • 资助金额:
    $ 9.09万
  • 项目类别:
    Studentship
Tumor hypoxia promotes acquired resistance to radiation through ferroptosis inhibition
肿瘤缺氧通过抑制铁死亡促进获得性放射抵抗
  • 批准号:
    10707129
  • 财政年份:
    2022
  • 资助金额:
    $ 9.09万
  • 项目类别:
Tumor hypoxia promotes acquired resistance to radiation through ferroptosis inhibition
肿瘤缺氧通过抑制铁死亡促进获得性放射抵抗
  • 批准号:
    10517144
  • 财政年份:
    2022
  • 资助金额:
    $ 9.09万
  • 项目类别:
Non-invasive, image-based, in-vivo assessment of tumor hypoxia to guide hypoxia-driven adaptive radiation therapy
对肿瘤缺氧进行非侵入性、基于图像的体内评估,以指导缺氧驱动的适应性放射治疗
  • 批准号:
    10661802
  • 财政年份:
    2022
  • 资助金额:
    $ 9.09万
  • 项目类别:
A personalized approach using hypoxia resolution to guide curative-intent radiation dose reduction to 30 Gy: A novel de-escalation paradigm for HPV-associated oropharynx cancers
使用缺氧解决方案指导治疗性辐射剂量减少至 30 Gy 的个性化方法:HPV 相关口咽癌的新型降级范例
  • 批准号:
    10372013
  • 财政年份:
    2020
  • 资助金额:
    $ 9.09万
  • 项目类别:
A personalized approach using hypoxia resolution to guide curative-intent radiation dose reduction to 30 Gy: A novel de-escalation paradigm for HPV-associated oropharynx cancers
使用缺氧解决方案指导治疗性辐射剂量减少至 30 Gy 的个性化方法:HPV 相关口咽癌的新型降级范例
  • 批准号:
    9887712
  • 财政年份:
    2020
  • 资助金额:
    $ 9.09万
  • 项目类别:
A personalized approach using hypoxia resolution to guide curative-intent radiation dose reduction to 30 Gy: A novel de-escalation paradigm for HPV-associated oropharynx cancers
使用缺氧解决方案指导治疗性辐射剂量减少至 30 Gy 的个性化方法:HPV 相关口咽癌的新型降级范例
  • 批准号:
    10117205
  • 财政年份:
    2020
  • 资助金额:
    $ 9.09万
  • 项目类别:
A personalized approach using hypoxia resolution to guide curative-intent radiation dose reduction to 30 Gy: A novel de-escalation paradigm for HPV-associated oropharynx cancers
使用缺氧解决方案指导治疗性辐射剂量减少至 30 Gy 的个性化方法:HPV 相关口咽癌的新型降级范例
  • 批准号:
    10570852
  • 财政年份:
    2020
  • 资助金额:
    $ 9.09万
  • 项目类别:
Effect of hypoxia on the repair process of radiation-induced DNA double-strand breaks
缺氧对辐射引起的DNA双链断裂修复过程的影响
  • 批准号:
    19K08215
  • 财政年份:
    2019
  • 资助金额:
    $ 9.09万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了